ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
10 announcements with these filters
Dr. Lal Path Labs' subsidiary completed the acquisition of an 80% stake in Sunshine Healthcare Limited, Ghana, for Rs.38.00 Crore. The target is now a subsidiary.
Dr. Lal PathLabs' subsidiary, DLPL Dubai, completed the acquisition of an 80% stake in Sunshine Healthcare Limited, Ghana. Sunshine Healthcare is now a step-down subsidiary.
Dr. Lal Path Labs Ltd. will acquire a 70% stake in SN Genelab Private Limited for Rs. 168 Crore to strengthen its genomics diagnostics portfolio.
Dr. Lal PathLabs approved the acquisition of a 70% stake in SN Genelab Private Limited for a total consideration of up to ₹199.5 Crore.
Dr. Lal Path Labs Ltd.'s subsidiary completed a 30% stake subscription in Neuome Technologies Private Limited for ₹3.50 Crore, making Neuome an associate company.
Dr. Lal PathLabs' subsidiary, Dr. Lal Ventures, has completed the acquisition of a 30% stake in Neuome Technologies Private Limited.
Dr. Lal Path Labs Ltd.'s subsidiary will acquire a 70% stake in Dr Lal PathLabs Indomed LLC to expand its diagnostics services in Uzbekistan.
Dr. Lal Path Labs Ltd. has completed the 100% acquisition of Shahbazkers Diagnostic Centre Private Limited (SDCPL) for ₹20 Crore. Following the transaction, SDCPL has become a wholly owned subsidiary of the company. This acquisition strengthens the company's diagnostic footprint.
Dr. Lal PathLabs Ltd. has successfully completed the 100% acquisition of Shahbazkers Diagnostic Centre Private Limited (SDCPL) on May 01, 2026. SDCPL is now a wholly-owned subsidiary of the company, following the terms of the Share Purchase Agreement signed on April 30, 2026.
Dr. Lal Path Labs Ltd. will acquire a 100% stake in Mumbai-based Shahbazkers Diagnostic Centre Private Limited for ₹20 Crore. The cash transaction is expected to conclude by May 31, 2026. This acquisition aims to strengthen the company’s diagnostic service presence in Mumbai, Maharashtra.